VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
OVID
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
OVIDOvid Therapeutics Inc.
$2.61$344M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksOVIDQuarterly Financials

Ovid Therapeutics Inc. (OVID) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Ovid Therapeutics Inc. (OVID) quarterly income statement — complete revenue, gross profit & net income history

OVID Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue0718K132K6.27M130K76K173K169K148K142K109K75K66K46.28K11.1K01.45M000
Revenue Growth %-100%844.74%-23.7%3611.24%-12.16%-46.48%58.72%125.33%124.24%206.83%881.81%--95.43%----99.31%-100%-100%-
Cost of Goods Sold35K000000000000000056.87K00
COGS % of Revenue--------------------
Gross Profit-35K718K132K6.27M130K76K173K169K148K142K109K75K66K46.28K11.1K01.45M-56.87K00
Gross Margin %-100%100%100%100%100%100%100%100%100%100%100%100%100%100%-100%---
Gross Profit Growth %-126.92%844.74%-23.7%3611.24%-12.16%-46.48%58.72%125.33%124.24%206.83%881.81%--95.43%181.38%---99.31%-101%-100%-
Operating Expenses17.81M13.01M12.65M11.35M12.68M10.8M13.4M20.69M17.57M18.33M12.14M14.25M14.96M12.22M12.81M14.3M17.71M26.3M11.68M14.31M
OpEx % of Revenue-1812.12%9587.12%180.88%9753.85%14207.89%7745.09%12240.24%11868.24%12908.45%11135.78%18996%22663.64%26402.75%115429.27%-1225.47%---
Selling, General & Admin6.67M6.42M6.79M4.88M6.02M6.78M5.54M8.1M7.17M6.19M6.8M7.25M8.34M7.36M7.63M8.26M9.88M8.23M6.76M6.63M
SG&A % of Revenue-894.43%5140.15%77.81%4631.54%8914.47%3204.62%4795.27%4843.24%4357.75%6243.12%9664%12642.42%15909.65%68744.37%-683.56%---
Research & Development11.15M6.59M5.87M6.46M6.66M5.92M7.86M12.58M10.4M10.64M5.33M6M6.62M5.56M5.18M6.05M7.83M18.07M4.92M7.68M
R&D % of Revenue-917.69%4446.97%103.08%5122.31%7793.42%4540.46%7444.97%7025%7494.37%4892.66%7998.67%10022.73%12005.63%46687.56%-541.89%---
Other Operating Expenses00000-1000K0101000K01000K-999-700K-2956172030341-842
Operating Income-17.85M-12.29M-12.52M-5.07M-12.55M-10.72M-13.23M-20.52M-17.42M-18.19M-12.03M-14.17M-14.89M-12.17M-12.8M-14.3M-16.27M-26.35M-11.68M-14.31M
Operating Margin %--1712.12%-9487.12%-80.88%-9653.85%-14107.89%-7645.09%-12140.24%-11768.24%-12808.45%-11035.78%-18896%-22563.64%-26302.75%-115329.27%--1125.47%---
Operating Income Growth %-42.2%-14.65%5.32%75.27%27.94%41.05%-9.95%-44.77%-16.96%-49.41%6.05%0.92%8.45%53.81%-9.61%0.06%-109.21%-22.06%28.79%38.15%
EBITDA-17.81M-12.28M-12.51M-4.97M-12.41M-10.56M-13.06M-20.37M-17.28M-18.05M-11.88M-14.04M-14.75M-11.99M-12.39M-13.85M-16.19M-26.3M-11.63M-14.26M
EBITDA Margin %--1709.75%-9475%-79.3%-9545.38%-13897.37%-7547.4%-12052.66%-11676.35%-12709.86%-10901.83%-18713.33%-22343.94%-25903.05%-111587.92%--1120.36%---
EBITDA Growth %-43.53%-16.23%4.21%75.58%28.19%41.48%-9.88%-45.13%-17.18%-50.55%4.08%-1.32%8.93%54.41%-6.53%2.86%-109.17%-22.26%28.76%38.17%
D&A (Non-Cash Add-back)35K17K16K99K141K160K169K148K136K140K146K137K145K184.98K415.37K452.48K73.81K56.87K52.18K53.22K
EBIT-17.85M-12.29M-12.52M-5.07M-12.55M-10.92M-13.23M-20.52M-17.42M-16.49M-12.03M-13.17M-14.89M-12.87M-12.8M-14.3M-16.27M-26.35M-11.68M-14.31M
Net Interest Income00000000000000000000
Interest Income00000000000000000000
Interest Expense00000000000000000000
Other Income/Expense858K21.96M365K389K2.31M1.47M-780K29.04M5.72M2.87M776K1.76M1.54M668.12K836.09K-284.13K209.05K3.9K2.66K-2.52K
Pretax Income-16.99M9.66M-12.16M-4.68M-10.23M-9.25M-14.01M8.52M-11.69M-15.32M-11.25M-12.41M-13.36M-11.5M-11.97M-14.59M-16.06M-26.35M-11.68M-14.32M
Pretax Margin %-1345.82%-9210.61%-74.68%-7873.08%-12175%-8095.95%5042.01%-7901.35%-10790.14%-10323.85%-16544%-20236.36%-24859.09%-107798.33%--1111%---
Income Tax000000000000000050K-349.71K-294.83K1.47M
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%-0.31%1.33%2.52%-10.29%
Net Income-16.99M9.66M-12.16M-4.68M-10.23M-9.25M-14.01M8.52M-11.69M-15.32M-11.25M-12.41M-13.36M-11.5M-11.97M-14.59M-16.11M-25.15M-11.38M-15.79M
Net Margin %-1345.82%-9210.61%-74.68%-7873.08%-12175%-8095.95%5042.01%-7901.35%-10790.14%-10323.85%-16544%-20236.36%-24859.09%-107798.33%--1114.46%---
Net Income Growth %-65.98%204.43%13.19%-154.97%12.48%39.61%-24.46%168.67%12.44%-33.18%5.97%14.95%17.09%54.26%-5.13%7.6%-109.15%-14.17%30.69%29.99%
Net Income (Continuing)-16.99M9.66M-12.16M-4.68M-10.23M-9.25M-14.01M8.52M-11.69M-15.32M-11.25M-12.41M-13.36M-11.5M-11.97M-14.59M-16.11M-26M-11.38M-15.79M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.230.12-0.17-0.07-0.14-0.13-0.200.12-0.17-0.22-0.16-0.18-0.19-0.16-0.16-0.21-0.23-0.38-0.17-0.23
EPS Growth %-64.29%192.31%15%-154.92%17.65%40.91%-25%166.67%10.53%-37.5%0%14.29%17.39%57.89%5.88%8.7%-109.09%-11.76%39.29%43.9%
EPS (Basic)-0.230.12-0.17-0.07-0.14-0.13-0.200.12-0.17-0.22-0.16-0.18-0.19-0.16-0.16-0.21-0.23-0.38-0.17-0.23
Diluted Shares Outstanding73.74M81.67M71.11M71.11M71.05M71.01M70.98M71.2M70.72M70.69M70.62M70.53M70.49M70.47M70.43M70.39M70.35M68.16M67.93M67.82M
Basic Shares Outstanding73.74M81.67M71.11M71.11M71.05M71.01M70.98M70.92M70.72M70.69M70.62M70.53M70.3M70.47M70.4M69.47M70.03M67.51M66.97M67.82M
Dividend Payout Ratio--------------------